RxDoctor Payments Data

Brittney Kuck

Nurse Practitioner · Asheville, NCNPI 1356625164

Payments from drug & device makers

$1,267in general payments, 2019–2025

Across 20 payments — averaging $63.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$260
  • Abiomed$229
  • Abbott$151
  • Novo Nordisk$133
  • Boehringer Ingelheim$131
  • Regeneron Healthcare Solutions, Inc.$106
  • plus $258 from 4 others

What the payments were for

  • Food & beverage$1,267100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,267 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$57,327
Medicare patients
371
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan215$190,974
EliquisApixaban111$103,636
JardianceEmpagliflozin106$84,112
Repatha SureclickEvolocumab21$23,638
Metoprolol Succinate327$3,433
Spironolactone235$1,565
Potassium Chloride121$1,410
Bumetanide44$1,172
Torsemide45$954
Eplerenone15$948
Losartan Potassium106$870
Isosorbide Mononitrate ErIsosorbide Mononitrate89$863
Rosuvastatin Calcium69$852
Ranolazine ErRanolazine14$822
Ezetimibe54$815

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$69$190,974215 claims
Boehringer IngelheimJardiance$131$84,112106 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →